GLP-1 medications , or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we approach diabetes mellitus . These injectable drugs function to mimicking the body’s https://jimwecd901034.jaiblogs.com/69044226/glp-1-a-significant-advance-in-glucose-management